Skip to main content
OpenTrials

Clinical trial condition

Skin Neoplasms

Explore clinical trials studying Skin Neoplasms. Study availability and eligibility vary by location and protocol.

2,109 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Skin Neoplasms trial results

Active, Not Recruiting

A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors

NCT05585320

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +29 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California San Diego San Diego, California, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)

NCT05155254

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +11 more
Locations
  • Mid Florida Hematology and Oncology Center Orange City, Florida, United States
  • Orlando Health Cancer Institute Orlando, Florida, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • VCU Massey Cancer Center Richmond, Virginia, United States
View all 112 locations
View Trial Details
Active, Not Recruiting

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

NCT05864144

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +101 more
Locations
  • UCLA Hematology/Oncology Los Angeles, California, United States
  • University of Colorado Cancer Center - Anschutz Medical Aurora, Colorado, United States
  • Norton Healthcare Louisville, Kentucky, United States
  • Henry Ford Cancer Detroit, Michigan, United States
View Trial Details
Active, Not Recruiting

A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

NCT03611868

Conditions
Cutaneous Melanoma, Eye Diseases, Eye Neoplasms, +33 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Highlands Oncology Rogers, Arkansas, United States
  • UCLA Hematology & Oncology Clinic Los Angeles, California, United States
  • Sarcoma Oncology Research Center Santa Monica, California, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib

NCT03235245

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations
  • University Hospitals Copenhagen - Herlev Hospital - University Copenhagen Herlev, Denmark
  • Odense University Hospital Odense, Denmark
  • Helsinki University Central Hospital - Dept of Oncology Helsinki, Finland
  • Tampere University Hospital Tampere, Finland
View all 38 locations
View Trial Details
Active, Not Recruiting

A Study of Ceralasertib Monotherapy and Ceralasertib Plus Durvalumab in Patients With Melanoma and Resistance to PD-(L)1 Inhibition

NCT05061134

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Sacramento, California, United States
  • Research Site San Francisco, California, United States
  • Research Site Tampa, Florida, United States
View all 66 locations
View Trial Details

Related conditions